Mankind Pharma Faces Rs 341.86 Cr Tax Demand

New Delhi: Mankind Pharma Ltd on Wednesday said it has received additional tax demands, including interest, of Rs 341.86 crore from the Income Tax authority.

The company has received orders from the office of the Deputy Commissioner of Income Tax, Central Circle 29, New Delhi dated May 9, 2025 on May 13 and 14, 2025, through IT portal, raising additional tax demands, including interest, of Rs 341.86 crore, Mankind Pharma said in a regulatory filing.

The demand is on account of adjustments made and disallowance of various expenditures under different sections of the Income Tax Act, 1961, it added.

The company said it believes that “the demands under the orders are not tenable in law”, asserting it has adequate factual and legal grounds to substantiate its position and does not expect any material impact on financials or its operations due to the orders.

Mankind Pharma said it would pursue an appeal against the said orders under applicable laws.

Related Posts

Diabetic drug metformin found to act on brain

NEW DELHI:  Cheap, effective and widely trusted, metformin has long been the first choice for treating type 2 diabetes. Now, scientists say the drug works in a way few had…

Hetero debuts semaglutide generic in emerging markets

New Delhi: Hyderabad-based drugmaker Hetero has announced the launch of its generic semaglutide portfolio in emerging international markets. In a phased global push, the company plans to roll out its…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Diabetic drug metformin found to act on brain

Diabetic drug metformin found to act on brain

Hetero debuts semaglutide generic in emerging markets

Hetero debuts semaglutide generic in emerging markets

LB Pharma Begins Pivotal Phase 3 Schizophrenia Trial

LB Pharma Begins Pivotal Phase 3 Schizophrenia Trial

Check manufacturing, sale of 26 unapproved drugs, central regulator tells state authority

Check manufacturing, sale of 26 unapproved drugs, central regulator tells state authority

Stem cell therapy for autism illegal: NMC advisory

Stem cell therapy for autism illegal: NMC advisory

India’s Essential Medicines Prices To Increase Marginally From 1 April Under Annual Pricing Framework

India’s Essential Medicines Prices To Increase Marginally From 1 April Under Annual Pricing Framework